|  |   | 
             
              | CHINDEX 
                  INTERNATIONAL ANNOUNCES CONFERENCE CALL TO DISCUSS ITS FISCAL 
                  2006 THIRD QUARTER RESULTS ON TUESDAY, FEBRUARY 14, 2006  |   
              |  |  BETHESDA, 
            Maryland, February 6, 2006 -- 
            Chindex International, Inc. (NASDAQ: CHDX 
            - News ) a leading independent American provider 
            of Western healthcare products and services in the People's Republic 
            of China, announced that it intends to release its financial results 
            for the third quarter ended December 31, 2005, on Monday February 
            13, 2006.    
             Chindex's 
            management will also host a conference call on Tuesday, February 14, 
            2006 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time; 12:00 a.m. 
            China time) to discuss its financial results.    
             To 
            participate, international callers dial 201-689-8565, domestic callers 
            dial 877-407-0778 approximately 
            10 minutes before the conference call is scheduled to begin.    
             The 
            telephone replay will be available two hours after the call at (international) 
            201-689-8565 and 
            (domestic) 877-407-0778, Account # 286, pass code 192041; and continue 
            to be available through February 28, 2006.    
             About 
            Chindex International, Inc.     
             Chindex 
            is an American healthcare company supplying both medical equipment 
            and healthcare services to the Chinese marketplace, including Hong 
            Kong . It sells medical equipment produced by a number of major multinational 
            companies including Siemens AG as its exclusive distribution partner 
            for the sales and servicing of color doppler ultrasound systems. It 
            also arranges financing packages for the supply of medical equipment 
            to hospitals in China utilizing the export loan and loan guarantee 
            programs of both the U.S. Export-Import Bank and the German KfW Development 
            Bank. It provides healthcare services through the operations of its 
            network of private primary care hospitals and affiliated ambulatory 
            clinics in China . With twenty-four years of experience, over 1,000 
            employees, and operations in the United States , China and Hong Kong 
            , the Company's strategy is to expand its cross-cultural reach by 
            providing leading edge healthcare technologies, quality products and 
            services to Greater China's professional communities. Further company 
            information may be found at the Company's websites, www.chindex.com 
             and www.unitedfamilyhospitals.com 
            .    
              Some 
            of the information in this press release may contain statements regarding 
            future expectations, plans, prospects for performance of the Company 
            that constitute forward-looking statements for purposes of the safe 
            harbor provisions of The Private Securities Litigation Reform Act 
            of 1995. The Company cannot guarantee future results, levels of activity, 
            performance or achievements. The numbers discussed in this press release 
            also involve risks and uncertainties. The following factors, among 
            others, could cause actual results to differ materially from those 
            described by such statements: our ability to manage our growth and 
            maintain adequate controls, our ability to obtain additional financing, 
            the loss of services of key personnel, general market conditions including 
            inflation or foreign currency fluctuations, our dependence on relationships 
            with suppliers, the timing of our revenues and fluctuations in financial 
            performance, the availability to our customers of third-party financings, 
            product liability claims and product recalls, competition, hiring 
            and retaining qualified sales and service personnel, management of 
            inventory, relations with foreign trade corporations, dependence on 
            sub-distributors and dealers, completion and opening of healthcare 
            facilities, attracting and retaining qualified physicians and other 
            hospital personnel, regulatory compliance, the cost of malpractice, 
            our dependence on our information systems, the economic policies of 
            the Chinese government, the newness and undeveloped nature of the 
            Chinese legal system, the regulation of the conversion of Chinese 
            currency, future epidemics in China such as SARS or Avian Flu, the 
            control over our operation by insiders, continuity of relationships 
            and variability of financial margins with existing suppliers, our 
            liquidity and availability of capital resources to meet cash requirements, 
            including capital expenditures, bid and performance bonds, limitations 
            on the inter-entity transfers and other limitations imposed by existing 
            credit facilities, uncertainty about the costs related to the closedown 
            of the Healthcare Products Distribution segment, and those other factors 
            contained in the section titled "Risk 
            Factors"  
            as set forth in the Company's Registration Statement (File No. 333-114996) 
            declared effective by the Securities and Exchange Commission on December 
            5, 2005, as well as other documents that may be filed by the Company 
            from time to time with the Securities and Exchange Commission. The 
            forward-looking statements and numbers contained herein represent 
            the judgment of the Company, as of the date of this press release, 
            and the Company disclaims any intent or obligation to update such 
            forward-looking statements to reflect any change in the Company's 
            expectations with regard thereto or any change in events, conditions, 
            circumstances on which such statements are based.    
             ###  
             |